Horimoto, Y., Arakawa, A., Harada-Shoji, N., Sonoue, H., Yoshida, Y., Himuro, T., . . . Saito, M. (2015). Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. Br J Cancer.
Styl ChicagoHorimoto, Y., et al. "Low FOXA1 Expression Predicts Good Response to Neo-adjuvant Chemotherapy Resulting in Good Outcomes for Luminal HER2-negative Breast Cancer Cases." Br J Cancer 2015.
Citace podle MLAHorimoto, Y., et al. "Low FOXA1 Expression Predicts Good Response to Neo-adjuvant Chemotherapy Resulting in Good Outcomes for Luminal HER2-negative Breast Cancer Cases." Br J Cancer 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..